MAPT and Alzheimer disease: Among 11 AD patients who carried the mutation p.G1347R, five met AD with dementia diagnostic criteria recommended by NIA‐AA in 2018,21 with CSF Aβ42 decreased or PIB‐PET positive and t‐tau or p‐181‐tau increased.